← Eichor
Study identifier: NCT03473912 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Meir Medical Center Rheumatologic Biobank

Condition: Rheumatoid Arthritis · Lupus Erythematosus, Systemic · Systemic Sclerosis  ·  Sponsor: Meir Medical Center

PhaseN/A
Planned participants500
Who can joinAll sexes, 18 Years to 120 Years
Healthy volunteersNo

About this study

Serum, synovial fluid and skin biopsies from patients will be collected to the biobank with rheumatoid diseases. These samples will later be used for clinical and basic research, following approval of each specific study by the IRB. The investigators intend to extract protein, DNA and RNA from each sample.

This description comes directly from the study's public registry record.

Talk to the study team

Yair Levy, Prof.  ·  972-9-7471524  ·  levy.yair@clalit.org.il

Noa Rabinowicz, Dr.  ·  972-9-7471992  ·  noa.rabinowicz@clalit.org.il

Always discuss trial participation with your own doctor first.

Locations (1)

Meir Medical CenterKfar Saba, IsraelRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03473912